Blanchette Rockefeller Neurosciences Institute

Bridging the Gap Between Research and Treatment

• About BRNI
  • Message from the CEO
  • Mission and Strategy
  • Our People
    • Institute Staff
    • Board of Directors
    • Scientific Advisory Board
  • Affiliations and Partnerships
    • WVU and WVUH
    • Marine Biological Laboratory
  • In Dedication
  • Contact Us
• Our Research
  • Research Overview
  • BRNI Research
    • Molecular Pathways of Memory
    • Target Identification and Drug Discovery
    • Diagnostics Development
    • Brain Science Technology
    • Memory and Neurological Disorder Modeling
  • Research Facilities
  • Patents/Publications
• BRNI In The News
  • Press Releases
  • Spotlight on BRNI
  • Media Resources
• Outreach Program
  • Mission and Plan of Work
  • Advisory Board
  • Physician Subcommittee
  • Statistics
  • In The News
  • Contact Us
• How You Can Help
  • Support BRNI
  • Giving Options
  • Make a Gift
  • In Appreciation
    • Partners in Science
    • Personal Tributes
  • Special Events

• FDA agrees to Phase II Drug Trial for Alzheimer's Disease

 

 

Printed from BRNI website: http://www.brni.org.

Blanchette Rockefeller Neurosciences Institute
Medical Center Drive PO Box 9301 Morgantown, WV 26506-9301
Phone: 304-293-3962   Fax: 304-293-7536   E-Mail: info@brni.org